Andrea Rowan-Carroll
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andrea Rowan-Carroll has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Ella Atlas
Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada
4 shared publications Luigi Lorusso
Chemical and Environmental Health Management Bureau, Health Canada , Ottawa
3 shared publicationsAndrew Williams
Environmental Health Science and Research Bureau (EHSRB), Health Canada , Ottawa, ON K1A 0K9
2 shared publications- Andrew Williams
Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada
2 shared publications Carole L Yauk
Department of Biology, University of Ottawa , Ottawa, ON K1N 9A4
2 shared publications- Geronimo Matteo
Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada
2 shared publications
Latest Publications
- Open Access
- 20 November 2026
- Published by Oxford University Press (OUP) in Toxicological Sciences
Chemical and transcriptomic analysis reveal time-dependent activation of lipid metabolism and suppression of immune pathways in human primary liver spheroids exposed to aqueous film-forming foams
Aqueous film-forming foams (AFFFs) are important sources of environmental and human exposure to per- and polyfluoroalkyl substances (PFAS), yet their mechanisms of action in human-relevant liver systems remain poorly defined. High-throughput transcriptomics (HTTr) provides a scalable approach for generating mechanistic evidence relevant to chemical hazard assessment. We applied HTTr in primary human liver spheroids to evaluate 12 AFFFs recovered from military sites across Canada following exposure to seven non-cytotoxic dilutions (0.01–0.1%) for 24 h or 10 d. Chemical characterization by high-resolution mass spectrometry revealed complex and variable PFAS profiles dominated by fluorotelomer-based substances, including fluorotelomer betaines and sulfonamidobetaines, with differing contributions from other PFAS classes. Transcriptomic biomarker and pathway analyses identified a pronounced time-dependent shift in the biological responses induced by AFFF exposure. At 24 h, most AFFFs predominantly activated cellular stress responses and pathways involved in lipid metabolism. By 10 d, these profiles transitioned toward widespread inhibition of immune and inflammatory signaling, accompanied by persistent disruption of metabolic pathways, including cholesterol biosynthesis and peroxisome proliferator-activated receptor alpha (PPARα) signaling. Despite differences in chemical composition, the tested AFFFs produced broadly concordant temporal response patterns characterized by early stress-associated transcriptional responses followed by sustained alterations in metabolic and immune-related pathways. These findings demonstrate the importance of exposure duration when evaluating complex PFAS-containing mixtures and provide mechanistic support for grouping diverse AFFF formulations and applying read-across approaches in hazard characterization.
- 20 November 2026
- Published by Oxford University Press (OUP) in Toxicological Sciences
Open AccessChemical and transcriptomic analysis reveal time-dependent activation of lipid metabolism and suppression of immune pathways in human primary liver spheroids exposed to aqueous film-forming foams
Aqueous film-forming foams (AFFFs) are important sources of environmental and human exposure to per- and polyfluoroalkyl substances (PFAS), yet their mechanisms of action in human-relevant liver systems remain poorly defined. High-throughput transcriptomics (HTTr) provides a scalable approach for generating mechanistic evidence relevant to chemical hazard assessment. We applied HTTr in primary human liver spheroids to evaluate 12 AFFFs recovered from military sites across Canada following exposure to seven non-cytotoxic dilutions (0.01–0.1%) for 24 h or 10 d. Chemical characterization by high-resolution mass spectrometry revealed complex and variable PFAS profiles dominated by fluorotelomer-based substances, including fluorotelomer betaines and sulfonamidobetaines, with differing contributions from other PFAS classes. Transcriptomic biomarker and pathway analyses identified a pronounced time-dependent shift in the biological responses induced by AFFF exposure. At 24 h, most AFFFs predominantly activated cellular stress responses and pathways involved in lipid metabolism. By 10 d, these profiles transitioned toward widespread inhibition of immune and inflammatory signaling, accompanied by persistent disruption of metabolic pathways, including cholesterol biosynthesis and peroxisome proliferator-activated receptor alpha (PPARα) signaling. Despite differences in chemical composition, the tested AFFFs produced broadly concordant temporal response patterns characterized by early stress-associated transcriptional responses followed by sustained alterations in metabolic and immune-related pathways. These findings demonstrate the importance of exposure duration when evaluating complex PFAS-containing mixtures and provide mechanistic support for grouping diverse AFFF formulations and applying read-across approaches in hazard characterization.
- Open Access
- 20 December 2025
- Published by Elsevier in Toxicology
- Vol. 521, 154375
Transcriptomic analysis of BPA alternative chemicals in primary human mammary epithelial cells
- 20 December 2025
- Published by Elsevier in Toxicology
- Vol. 521, 154375
Open AccessTranscriptomic analysis of BPA alternative chemicals in primary human mammary epithelial cells
- Open Access
- 12 June 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 207 (1) , 161-180
Identification of four mechanisms of toxicity for per- and polyfluoroalkyl substances through transcriptomic profiling in human liver spheroids exposed to 24 PFAS
Per- and polyfluoroalkyl substances (PFAS) are persistent and widespread contaminants. Epidemiological effects of PFAS include increased serum cholesterol, decreased immune response to vaccination and disease, and increased incidence of cancer; however, PFAS modes of action remain unclear. Herein, we analyzed gene expression data from human liver spheroids that were exposed to several concentrations of 24 different PFAS. Benchmark concentration (BMC) response modeling was used to identify the 250 lowest gene BMCs for each PFAS. Hierarchical clustering analysis revealed 4 functionally diverse gene sets. Each gene set was affected by a distinct group of PFAS, whereas individual PFAS were usually part of more than 1 PFAS group. The biological roles of these gene sets relate to: (1) cholesterol biogenesis and cholesterol clearance (downregulated by 7 fluorocarbon or longer PFAS), putatively through discordance of cholesterol sensing by SCAP and LXR due to membrane integration of PFAS; (2) lipolysis (upregulated by 8 carbon or shorter PFAS); (3) innate immunity (downregulated by most PFAS); and (4) adaptive immunity (downregulated by sulfonate-type PFAS). The distinctions between the 4 PFAS groups suggest that PFAS can act through at least 4 independent mechanisms. The molecular characteristics of each PFAS group may be useful for understanding the molecular interactions leading to their effect on gene expression. Inclusion of some PFAS congeners in more than one PFAS group suggests that individual PFAS can act through multiple unrelated molecular interactions. This transcriptomic analysis offers a major advancement to the understanding of the molecular mechanisms underlying the effects of PFAS exposure and provides guidance for future work that may strengthen links between PFAS exposure and their proposed effects on human health.
- 12 June 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 207 (1) , 161-180
Open AccessIdentification of four mechanisms of toxicity for per- and polyfluoroalkyl substances through transcriptomic profiling in human liver spheroids exposed to 24 PFAS
Per- and polyfluoroalkyl substances (PFAS) are persistent and widespread contaminants. Epidemiological effects of PFAS include increased serum cholesterol, decreased immune response to vaccination and disease, and increased incidence of cancer; however, PFAS modes of action remain unclear. Herein, we analyzed gene expression data from human liver spheroids that were exposed to several concentrations of 24 different PFAS. Benchmark concentration (BMC) response modeling was used to identify the 250 lowest gene BMCs for each PFAS. Hierarchical clustering analysis revealed 4 functionally diverse gene sets. Each gene set was affected by a distinct group of PFAS, whereas individual PFAS were usually part of more than 1 PFAS group. The biological roles of these gene sets relate to: (1) cholesterol biogenesis and cholesterol clearance (downregulated by 7 fluorocarbon or longer PFAS), putatively through discordance of cholesterol sensing by SCAP and LXR due to membrane integration of PFAS; (2) lipolysis (upregulated by 8 carbon or shorter PFAS); (3) innate immunity (downregulated by most PFAS); and (4) adaptive immunity (downregulated by sulfonate-type PFAS). The distinctions between the 4 PFAS groups suggest that PFAS can act through at least 4 independent mechanisms. The molecular characteristics of each PFAS group may be useful for understanding the molecular interactions leading to their effect on gene expression. Inclusion of some PFAS congeners in more than one PFAS group suggests that individual PFAS can act through multiple unrelated molecular interactions. This transcriptomic analysis offers a major advancement to the understanding of the molecular mechanisms underlying the effects of PFAS exposure and provides guidance for future work that may strengthen links between PFAS exposure and their proposed effects on human health.
- Open Access
- 4 March 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 205 (1) , 124-142
Deciphering per- and polyfluoroalkyl substances mode of action: comparative gene expression analysis in human liver spheroids
Understanding the mechanisms by which environmental chemicals cause toxicity is necessary for effective human health risk assessment. High-throughput transcriptomics (HTTr) can be used to inform risk assessment on toxicological mechanisms, hazards, and potencies. We applied HTTr to elucidate the molecular mechanisms by which per- and polyfluoroalkyl substances (PFAS) cause liver perturbations. We contrasted transcriptomic profiles of PFOA, PFBS, PFOS, and PFDS against transcriptomic profiles from established liver-toxic and non-toxic reference compounds, alongside peroxisome proliferator-activated receptors (PPARs) agonists. Our analysis was conducted on metabolically competent 3-D human liver spheroids produced from primary cells from 10 donors. Pathway analysis showed that PFOS and PFDS perturb many of the same pathways as the known liver-toxic compounds in the spheroids, and that the cholesterol biosynthesis pathways are significantly affected by exposure to these compounds. PFOA alters lipid metabolism-related pathways but its expression profile does not closely match reference compounds. PFBS upregulates many degradation-related pathways and targets many of the same pathways as the PPAR agonists and acetaminophen. Our transcriptional analysis does not support the claim that these PFAS are DNA-damaging in this model. A multidimensional scaling (MDS) analysis revealed that PFOS, PFOA, and PFDS cluster together in the same multidimensional space as liver-damaging compounds, whereas PFBS clusters more closely with the non-liver-damaging compounds. Benchmark concentration-response modeling predicts that all the PFAS are bioactive in the liver. Overall, our results show that these PFAS produce unique transcriptional changes but also alter pathways associated with established liver-toxic chemicals in this liver spheroid model.
- 4 March 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 205 (1) , 124-142
Open AccessDeciphering per- and polyfluoroalkyl substances mode of action: comparative gene expression analysis in human liver spheroids
Understanding the mechanisms by which environmental chemicals cause toxicity is necessary for effective human health risk assessment. High-throughput transcriptomics (HTTr) can be used to inform risk assessment on toxicological mechanisms, hazards, and potencies. We applied HTTr to elucidate the molecular mechanisms by which per- and polyfluoroalkyl substances (PFAS) cause liver perturbations. We contrasted transcriptomic profiles of PFOA, PFBS, PFOS, and PFDS against transcriptomic profiles from established liver-toxic and non-toxic reference compounds, alongside peroxisome proliferator-activated receptors (PPARs) agonists. Our analysis was conducted on metabolically competent 3-D human liver spheroids produced from primary cells from 10 donors. Pathway analysis showed that PFOS and PFDS perturb many of the same pathways as the known liver-toxic compounds in the spheroids, and that the cholesterol biosynthesis pathways are significantly affected by exposure to these compounds. PFOA alters lipid metabolism-related pathways but its expression profile does not closely match reference compounds. PFBS upregulates many degradation-related pathways and targets many of the same pathways as the PPAR agonists and acetaminophen. Our transcriptional analysis does not support the claim that these PFAS are DNA-damaging in this model. A multidimensional scaling (MDS) analysis revealed that PFOS, PFOA, and PFDS cluster together in the same multidimensional space as liver-damaging compounds, whereas PFBS clusters more closely with the non-liver-damaging compounds. Benchmark concentration-response modeling predicts that all the PFAS are bioactive in the liver. Overall, our results show that these PFAS produce unique transcriptional changes but also alter pathways associated with established liver-toxic chemicals in this liver spheroid model.